CIK 0001730430 · Large accelerated filer
Kiniksa Pharmaceuticals International, plc
Sign in to watch- Ticker
- KNSA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 981795578
- Phone
- 7814319100
- Business address
- 105 PICCADILLY, SECOND FLOOR, LONDON, United Kingdom, W1J 7NJ
- Former names
- Kiniksa Pharmaceuticals, Ltd.
- 8-K Event Other events
- 4 Planned sale CHAIRMAN & CEO sold 65,012 shares at $21.02 ($1,366,552)
- 4 Planned sale CHAIRMAN & CEO sold 18,324 shares at an average $21.34 ($391,056)
- 4 Planned sale CHIEF OPERATING OFFICER sold 1,189 shares at $22.03 ($26,194)
- 4 Planned sale CHIEF MEDICAL OFFICER sold 18,844 shares at $21.77 ($410,234)
- 144 Insider Sale of Securities
- 4 Planned sale CHIEF ACCOUNTING OFFICER sold 14,785 shares at an average $21.57 ($318,881)
- 144 Insider Sale of Securities
- 4 Planned sale CHIEF MEDICAL OFFICER sold 10,156 shares at $21.03 ($213,581)
- S-8 Other Securities Offered to Employees in Benefit Plans
- 144 Insider Sale of Securities
- 10-K Report Annual Report
- 8-K Event Results of operations
- 144 Insider Sale of Securities
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G Stake Amended Statement of Ownership
- SC 13G Stake Amended Statement of Ownership
- 4 Planned sale CHIEF FINANCIAL OFFICER sold 12,000 shares at $20.00 ($240,000)
Page 19 of 39 · 778 filings